Early achievement of measurable residual disease (MRD)-negative complete remission as predictor of outcome after myeloablative allogeneic hematopoietic cell transplantation in acute myeloid leukemia.
Alexander P HoffmannAshley L BeschMegan K D OthusLinde M MorsinkBrent L WoodMarco MielcarekElihu H EsteyFrederick R AppelbaumRoland Bruno WalterPublished in: Bone marrow transplantation (2019)